News | April 29, 2025
Pfizer Q1 2025 revenue drops 8% to $13.7 billion
Delivers robust earnings performance, successfully navigating a dynamic environment
Delivers robust earnings performance, successfully navigating a dynamic environment
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The supply of these goods is set to commence within the first quarter of FY26
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Findings likely to generate hypotheses about potential new uses of drugs
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The freshly infused capital will primarily be deployed towards expansion and research & development
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
Subscribe To Our Newsletter & Stay Updated
